Molecular Imaging and Contrast Agent Database adds 15 agents

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
Molecular Imaging and Contrast Agent Database (MICAD) has added 15 molecular imaging and contrast agents, totaling 913 agents in the MICAD database.

The new PET agents are:
  • anti-3-[18F]FACBC which targets L-type amino acid transporter;
  • [18F]FP-(+)-DTBZ ([18F]AV-133) which targets type 2 vesicular monoamine transporter (VMAT2);
  • [18F]7c which targets beta-amyloid;
  • [18F]PipISB which targets cannabinoid CB1 receptors;
  • [11C]DTBZ which targets type 2 vesicular monoamine transporter (VMAT2);
  • [11C]PipISB which targets cannabinoid CB1 receptors;
  • [64Cu]-AmBaSar-RGD which targets alpha v beta 3 integrin;
  • [64Cu]-AmBaSar which is non-targeted;
  • 68Ga-DOTA-Lys40-exendin-3 which targets glucagon-like peptide-1 receptor (GLP-1R);
  • 68Ga-DOTA-ZHER2:342-pep2 which targets epidermal growth factor receptor (HER2); and
  • 86Y-CHX-A''-DTPA-cetuximab which targets epidermal growth factor receptor (HER1).

The new SPECT agents are:
  • 111In-DTPA-Lys40-exendin-3 which targets glucagon-like peptide-1 receptor (GLP-1R); and
  • [99mTc]5 which targets carbonic anhydrase IX.

The new optical agent is:
  • IR-783 which targets lysosomes and mitochondria.

The new multimodality agent is: 
  • Cy5.5-CNP-Gd(III) which is non-targeted.